CTRI/2022/04/041610已完成3 期
A randomized, double blind, placebo-controlled study to evaluate the Efficacy and safety profile of Active Metabolites of B. subtilis (B-2335) in Healthy Subjects - AMEBS
PRG Pharma Pvt Ltd0 个研究点目标入组 108 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Free from any disorders or diseases
- •2. Willing to provide information on questionnaires either in person or electronically or via phone
- •3. Willing to comply with the study dose consumption.
排除标准
- •1. Currently being treated for any physician diagnosed diseases.
- •2. Having a Body Mass Index of <20kg/m2 or > 30 kg/m2
- •3. Currently taking a probiotic or probiotic. Individuals who currently report as taking a probiotic will be allowed entry into study protocol if a wash-out period of 30 days is observed.)
- •4. Currently consuming any form of dietary supplements. Individuals who currently report as taking any type of supplements will be allowed entry into study protocol if a wash-out period of 30 days is observed.
- •5. Women who are lactating, know that they are pregnant or are attempting to get pregnant.
- •6. Have received chemotherapy or other immune suppressing therapy within the last year
研究者
相似试验
进行中（未招募）
不适用
Effect of treatment with the painkiller tapentadol on pain in patients with fibromyalgiaFibromyalgiaEUCTR2015-005258-37-NLMC
已完成
不适用
A randomized, double blind, placebo-controlled study on the effect of 3 months treatment with the analgesic tapentadol on conditioned pain modulation (CPM) and pain relief in patients with chronic low back pailow back pain10028377NL-OMON42741eids Universitair Medisch Centrum40
尚未招募
3 期
A randomized, double blind, placebo-controlled study evaluating efficacy of Topical Aloe Vera Gel for prevention of radiation dermatitis in head and neck cancer patients receiving concurrent chemoradiotherapyearly stage of locally advance stage of head and neck cancerhead and neck cancerTCTR20230707005avamindradhiraj University Research fund130
进行中（未招募）
1 期
Safety and effect of QBW276 in patients with cystic fibrosisMedDRA version: 20.0 Level: PT Classification code 10011762 Term: Cystic fibrosis System Organ Class: 10010331 - Congenital, familial and genetic disordersCystic FibrosisEUCTR2014-004915-35-DEovartis Pharma AG16
已完成
不适用
A randomized, double blind, placebo-controlled study on the effect of 3 months treatment with the analgesic tapentadol on conditioned pain modulation (CPM) and pain relief in patients with chronic pain from fibromyalgiachronic widespread pain10028302NL-OMON42796eids Universitair Medisch Centrum40